NATHAN GILBERT: Open Payments
NPI 1255087839 · COLUMBUS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$269 in 12 payments from 12 companies in 2025. Trend: 2023 $145 · 2024 $175 · 2025 $269
Food & beverage: $269
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 1 | $27 |
| Adaptive Biotechnologies Corporation | 1 | $27 |
| Corcept Therapeutics | 1 | $27 |
| SOBI, INC | 1 | $25 |
| Becton, Dickinson and Company | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Novartis Pharmaceuticals Corporation | 1 | $22 |
| PharmaEssentia USA Corporation | 1 | $21 |
| Genentech USA, Inc. | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
Products named: KEYTRUDA, clonoSEQ, Korlym, Doptelet, AllPoints, FRUZAQLA, KISQALI, BESREMI.
Industry payments across IN — which companies pay providers there.
